[Cogan-I-syndrome. A rare diffenrential diagnosis in progressive sensorineural hearing loss].
Strathmann
S
S
Burmester
G-R
GR
Rüther
K
K
Olze
H
H
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D001301:Audiometry, Pure-Tone; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000188:drug therapy; D003231:Conjunctivitis / Q000175:diagnosis / Q000188:drug therapy; D003318:Corneal Opacity / Q000175:diagnosis / Q000188:drug therapy; D003937:Diagnosis, Differential; D018450:Disease Progression; D005260:Female; D003639:Hearing Loss, Sudden / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007262:Infusions, Intravenous; D007634:Keratitis / Q000175:diagnosis / Q000188:drug therapy; D009759:Nystagmus, Pathologic / Q000188:drug therapy / Q000209:etiology*; D010348:Patient Care Team; D012008:Recurrence; D012017:Referral and Consultation; D013577:Syndrome; D014012:Tinnitus / Q000188:drug therapy / Q000209:etiology*; D014717:Vertigo / Q000188:drug therapy / Q000209:etiology*; D000160:Vestibulocochlear Nerve Diseases / Q000175:diagnosis* / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D006895:Hydroxyethyl Starch Derivatives; D007166:Immunosuppressive Agents